Here, we establish Tiam1 as an essential factor in the pathophysiology of comorbid depression in chronic pain through its regulation of maladaptive synaptic plasticity in ACC neurons, which can be targeted by ketamine to produce sustained antidepressant-like effects. This evidence concerns the gene TIAM1 and depressive symptom measurement.